AMS  Clinical Research Teams & Indications

Indication-specialized teams will take care:

As part of the AMS company philosophy, indication-specialized teams are set up to strengthen special therapeutic experience across all areas of the Clinical Research services provided.
The AMS Clinical Research team includes experienced physicians who continuously support all projects in multiple aspects of project performance, such as:

  • Clinical trial design
  • Protocol set-up
  • Site and patient selection
  • Medical review
  • Medical input to final report

Our specialized teams have broad experience in various specific indications from a large number of trials conducted at AMS. To ensure the most recent and in-depth knowledge of highly specific indications and study procedures, our study teams and clinical research associates are regularly trained.

Please find AMS' Clinical Research Indication Experience here.

Get in touch with us at:

Your direct Contact:

Kathryn_Hutchinson
Kathryn Hutchinson
Director Regulatory Affairs
Harald_Wagner
Harald Wagner
Director Clinical Operations
Antje_Dombrowski
Antje Dombrowski
Director Clinical Operations
Rolf-Dietrich Tiemann
Rolf-Dietrich Tiemann
Director Biostatistics and Data Management
Hassan_Kazerooni
Hassan Kazerooni
Director Data Management
Kerstin_Doepfner
Dr. med. Kerstin Döpfner-Ozean
Director Clinical Safety
Hanna_Neymeyer
Dr. rer. nat. Hanna Neymeyer
Director Medical Writing

• 2022 – AMS are CTR- and MDR ready • 2022 – New unique AMS-ePRO® features launched • 2022 – Real-World Evidence focus in AMS Late-Stage Research • 2022 – AMS expanded its global reach • 2021 – DIGA dossier submission pioneer •

News